- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00663663
Telephone Intervention for Pain Study (TIPS) (TIPS)
August 29, 2013 updated by: Dawn Ehde, University of Washington
Efficacy of Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain
Treatments teaching people how to manage pain have been used to treat chronic pain in the general population.
The purpose of this study is to see if these treatments delivered over the telephone can benefit persons with multiple sclerosis, spinal cord injury or an acquired amputation.
Specifically, we want to determine if these treatments can help reduce the negative consequences that pain often causes in terms of a person's mood, daily activities, and enjoyment of life.
We are also interested in finding out if these treatments decrease a person's pain.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
207
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Definitive diagnosis of acquired amputation (AMP), multiple sclerosis (MS), or spinal cord injury (SCI) confirmed by participants' primary care physicians
- Average pain intensity in the past month of greater than 3 on 0-10 numeric rating scale;
- Pain is either worse or started since the onset of the disability;
- Pain of at least six months duration, with pain reportedly present greater than or equal to half of the days in the past six months;
- Read, write and understand English;
- Must be able to communicate over the phone (i.e., must be verbal);
- Age 18 years or older.
Exclusion Criteria:
- Cognitive impairment defined as one or more errors on the Six-Item screener (Callahan et al., 2002).
- Current or previous participation in a psychological treatment for pain (obtained via self-report).
- Current participation in a psychological treatment for any reason on a regular basis(obtained via self-report).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Intervention 1 will consist of eight 60-minute sessions conducted by phone over eight weeks (1 session/week on average).
Intervention 1 will include: (1) education about the role of cognitions (particularly catastrophizing) and pain beliefs (including control) in chronic pain and adjustment; (2) instruction in how to identify negative thinking and cognitive distortions about pain; (3) instruction in thought-stopping and cognitive-restructuring techniques, including challenging negative thoughts and core beliefs about pain; (4) instruction in utilization of positive coping self-statements; (5) relaxation techniques; (6) activity pacing and scheduling; (7) coping with pain flare-ups; and (8) relapse prevention/maintenance of gains.
Each intervention 1 session will include a brief relaxation exercise practiced over the phone.
|
Intervention 1 will consist of eight 60-minute sessions conducted by phone over eight weeks.
Intervention 1 will include: (1) education about the role of cognitions (particularly catastrophizing) and pain beliefs (including control) in chronic pain and adjustment; (2) instruction in how to identify negative thinking and cognitive distortions about pain; (3) instruction in thought-stopping and cognitive-restructuring techniques, including challenging negative thoughts and core beliefs about pain; (4) instruction in utilization of positive coping self-statements; (5) relaxation techniques; (6) activity pacing and scheduling; (7) coping with pain flare-ups; and (8) relapse prevention/maintenance of gains.
Each intervention 1 session will include a brief relaxation exercise practiced over the phone.
|
|
Experimental: 2
Intervention 2 will consist of eight 60-minute sessions conducted by phone over eight weeks (1 session/week on average), scheduled at times convenient for participants (including evenings and weekends if necessary).
The sessions will cover a variety of topics, including the definition of chronic pain, the physiological processes underlying chronic pain, common pain-related conditions such as sleep disturbance, and the effects of chronic pain.
|
Intervention 2 will consist of eight 60-minute sessions conducted by phone over eight weeks (1 session/week on average), scheduled at times convenient for participants (including evenings and weekends if necessary).
The sessions will cover a variety of topics, including the definition of chronic pain, the physiological processes underlying chronic pain, common pain-related conditions such as sleep disturbance, and the effects of chronic pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Average pain intensity
Time Frame: Four times in a 7-day period Pre-Treatment, Mid-Treatment, Post-Treatment, and Follow-up (6 and 12 months post-randomization).
|
Four times in a 7-day period Pre-Treatment, Mid-Treatment, Post-Treatment, and Follow-up (6 and 12 months post-randomization).
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Physical Functioning-Brief Pain Inventory (Cleeland & Ryan, 1994)
Time Frame: pre-treatment, mid-treatment, post-treatment, and follow-up (6 and 12 months post-randomization).
|
pre-treatment, mid-treatment, post-treatment, and follow-up (6 and 12 months post-randomization).
|
|
Patient Health Questionnaire-8 (PHQ-8) (Kroenke & Spitzer, 2002)
Time Frame: pre-treatment, mid-treatment, post-treatment, and follow-up (6 and 12 months post-randomization).
|
pre-treatment, mid-treatment, post-treatment, and follow-up (6 and 12 months post-randomization).
|
|
Pain Catastrophizing Scale (Sullivan et al., 1995)
Time Frame: pre-treatment, mid-treatment, post-treatment, and followup (6 and 12 months post-randomization)
|
pre-treatment, mid-treatment, post-treatment, and followup (6 and 12 months post-randomization)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Dawn M. Ehde, Ph.D, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
April 18, 2008
First Submitted That Met QC Criteria
April 18, 2008
First Posted (Estimate)
April 22, 2008
Study Record Updates
Last Update Posted (Estimate)
August 30, 2013
Last Update Submitted That Met QC Criteria
August 29, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Pain
- Neurologic Manifestations
- Wounds and Injuries
- Trauma, Nervous System
- Spinal Cord Diseases
- Multiple Sclerosis
- Chronic Pain
- Spinal Cord Injuries
Other Study ID Numbers
- 33597-G
- R01HD057916-04 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.